Skip to main content
. 2013 Jun 11;1:e87. doi: 10.7717/peerj.87

Table 1. Characteristics of the overall cohort of patients with type 2 diabetes.

BIG MEG SFU TZD Missing
n 14708 773 12606 4980
Continuousa variables
Age 57.8 66.4 66.4 61.9 0
Body Mass Index 33.6 30.4 31.1 33.3 13986
Hemoglobin A1c (%) 7.8 7.1 7.7 7.8 16717
Systolic BP (mm of Hg) 133.2 133.5 135.1 133.5 6482
Diastolic BP (mm of Hg) 77.7 72.7 75 74.4 6489
LDL (mg/dl) 109.4 93.7 105.9 105.7 17347
HDL (mg/dl) 47.1 46.8 45.8 46.3 16653
Triglycerides (mg/dl) 203.7 174.8 202.5 210.6 16861
GFR (ml/min) 75.5 58 66.3 65.7 10702
Income 45047.2 43768.1 43999.7 43851.7 702
Categoricalb variables
Male 6733 (45.8) 418 (54.1) 6961 (55.2) 2600 (52.2) 2
Caucasian 10778 (76.2) 626 (83.7) 9553 (78.2) 3917 (81.8) 1175
Heart Failure 431 (2.9) 97 (12.6) 1030 (8.2) 255 (5.1) n/a
Coronary Heart Disesae 1528 (10.4) 147 (19.0) 1790 (14.2) 688 (13.8) n/a
Insulin 1934 (13.2) 214 (27.7) 1371 (10.9) 1568 (31.5) n/a
Aspirin 3566 (24.3) 243 (31.4) 3171 (25.2) 1325 (26.6) n/a
Plavix 929 (6.3) 98 (12.7) 1059 (8.4) 516 (10.4) n/a
ACE-I/ARB 7286 (49.5) 443 (57.3) 6699 (53.1) 2921 (58.7) n/a
Atrial Fibrillation 476 (3.2) 50 (6.5) 757 (6.0) 191 (3.8) n/a
Cholesterol Medication 7098 (48.3) 409 (52.9) 5630 (44.7) 2911 (58.5) n/a
New Diabetes 3140 (21.4) 37 (4.8) 1002 (8.0) 399 (8.0) n/a
Hypertension Medication 10242 (69.6) 639 (82.7) 9976 (79.1) 3939 (79.1) n/a
Warfarin 858 (5.8) 120 (15.5) 1473 (11.7) 399 (8.0) n/a
Smoking Status 8195
Never 5763 (49.0) 254 (46.7) 3941 (44.4) 1643 (44.7)
Quit 4126 (35.1) 239 (43.9) 3649 (41.1) 1461 (39.7)
Current 1877 (16.0) 51 (9.4) 1293 (14.6) 575 (15.6)

Notes.

a

Mean.

b

Count (%).

BIG = Biguanide.

MEG = Meglitinide.

SFU = Sulfonylurea.

TZD = Thiazolidinedione.

BP = Blood Pressure.

LDL = Low Density Lipoprotein.

HDL = High Density Lipoprotein.

GFR = Glomerular Filtration Rate.

ACE-I/ARB = Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker.